Riskpilot← Back to searchSign inGet full accessTermino C 14644 AB
ABDissolvedOrg 5592023344General medical practice activities · NACE 8621Est. 20190 employees
Revenue 2025
SEK 100K
0% vs 2024
EBITDA margin
-180.0%
-1364% vs 2024
Equity ratio
93.8%
Financial strength
Net profit 2025
SEK -180K
-1360% vs 2024
| Revenue | SEK 100K | +0% |
| EBITDA | SEK -180K | -1364% |
| Net profit | SEK -180K | -1360% |
| Total assets | SEK 32K | -34% |
| Equity | SEK 30K | +19% |
| Employees | 0 | — |
Legal name
Termino C 14644 AB
Org number
5592023344
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 april 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 100 | 100 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −6 | −4 | −2 | −12 | −180 |
| Depreciation & amort. | −0 | −0 | — | — | −0 |
| EBIT | −6 | −4 | −2 | −12 | −180 |
| Net financials | — | — | −0 | −0 | — |
| Profit before tax | −6 | −4 | −2 | −12 | −180 |
| Tax | −0 | −0 | — | — | −0 |
| Net profit | −6 | −4 | −2 | −12 | −180 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 44 | 41 | 38 | 48 | 32 |
| Equity | 44 | 40 | 37 | 25 | 30 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 0 | 1 | 1 | 23 | 2 |
| Total debt | — | 1 | 1 | 23 | 2 |
EBITDA margin
-180.0%
This company
15.8%
Market median
-1239% vs market
20212025
Equity ratio
93.8%
This company
38.2%
Market median
+146% vs market
20212025
Return on equity
-600.0%
This company
18.4%
Market median
-3361% vs market
20212025
Net profit margin
-180.0%
This company
8.1%
Market median
-2322% vs market
20212025
Asset turnover
3.13×
This company
1.12×
Market median
+179% vs market
20212025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
| Former (6) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2026 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2026 | |
| Deputy Board Member | 2020 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 14644 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emilie Henrietta Collett | Chairman | 0 companies |
| Naga Yamuna Nalluri | Board of Directors | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Anna Jennifer Elisabeth Sundström | Board of Directors | 0 companies |
| Naga Padmaja Nalluri | Board of Directors | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Sami Chouchi | Chairman | 0 companies |
| Per Jörgen Sundström | Deputy Board Member | 0 companies |